# clm_03FC6245728F

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 3,158,100,000 United States dollar  
valid_from: 2023-06-30  
valid_to: 2023-09-30  
published: 2023-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D14890ED012F  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 3,158,100,000 United States dollar", as of 2023-06-30 (until 2023-09-30). Claim clm_03FC6245728F, https://asof.is/claim/clm_03FC6245728F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2023, filed 2023-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422023000023/0001804220-23-000023-index.htm (primary, SEC EDGAR 10-Q Q2 FY2023, published 2023-08-03)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,162,100,000 United States dollar | valid 2023-03-31 to 2023-06-30 | conf 0.95 | superseded | superseded_by [clm_03FC6245728F](/claim/clm_03FC6245728F.md) | [clm_179FAEBC31F3](/claim/clm_179FAEBC31F3.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.